Crescent Capital BDC (CCAP) Set to Post Earnings on Monday

Crescent Capital BDC (NASDAQ:CCAP) is projected to issue its Q3 2026 results after the market closes on Monday, November 9th. Analysts expect Crescent Capital BDC to post earnings of $0.35 per share and revenue of $36.37 million for the quarter. Investors may review the information on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Tuesday, November 10, 2026 at 12:00 PM ET.

Crescent Capital BDC (NASDAQ:CCAP) last released its quarterly earnings results on Monday, August 10th. The company reported $0.36 EPS for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.01). Crescent Capital BDC had a positive return on equity of 9.02% and a negative net margin of 2.02%. The business had revenue of $5.12 million for the quarter, compared to the consensus estimate of $37.12 million. On average, analysts expect Crescent Capital BDC to post $1.49 EPS for the current fiscal year and $1.42 EPS for the next fiscal year.

Crescent Capital BDC Price Performance

NASDAQ:CCAP traded down $0.13 during mid-day trading on Tuesday, reaching $9.28. 55,900 shares of the company were exchanged, compared to its average volume of 230,156. Crescent Capital BDC has a 12 month low of $8.40 and a 12 month high of $15.18. The company has a quick ratio of 1.30, a current ratio of 1.30 and a debt-to-equity ratio of 1.41. The company has a fifty day moving average of $9.57 and a 200 day moving average of $11.69. The stock has a market cap of $341.78 million, a PE ratio of -103.07 and a beta of 0.57.

Crescent Capital BDC Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Wednesday, September 30th were paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 14.7%. The ex-dividend date of this dividend was Wednesday, September 30th. Crescent Capital BDC’s dividend payout ratio (DPR) is -1,511.11%.

Analyst Ratings Changes

Several analysts have weighed in on CCAP shares. Wells Fargo & Company dropped their price objective on Crescent Capital BDC from $12.00 to $11.00 and set an “equal weight” rating for the company in a report on Wednesday, August 12th. Keefe, Bruyette & Woods lowered shares of Crescent Capital BDC from an “outperform” rating to a “market perform” rating and cut their target price for the stock from $13.00 to $12.00 in a report on Monday, August 17th. B. Riley Financial reduced their price target on shares of Crescent Capital BDC from $13.50 to $12.50 and set a “neutral” rating on the stock in a research report on Wednesday, August 12th. Zacks Research raised shares of Crescent Capital BDC from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 21st. Finally, Raymond James Financial set a $10.00 price objective on shares of Crescent Capital BDC in a research report on Thursday, October 22nd. One analyst has rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, Crescent Capital BDC currently has a consensus rating of “Hold” and an average target price of $12.25.

Insider Activity

In related news, major shareholder & Guaranty Life Insur Fidelity sold 139,054 shares of the stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $10.23, for a total transaction of $1,422,522.42. Following the completion of the sale, the insider directly owned 3,680,307 shares of the company’s stock, valued at approximately $37,649,540.61. This represents a 3.64% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 451,543 shares of company stock valued at $4,689,738. 1.23% of the stock is currently owned by insiders.

About Crescent Capital BDC

Crescent Capital BDC, Inc is a business development company that provides financing to middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by investing in privately negotiated debt and equity securities.

Its investment portfolio is focused primarily on senior secured loans, including first-lien and second-lien loans, as well as other debt investments and selected equity interests. Crescent Capital BDC generally works with established companies across a range of industries, providing capital for acquisitions, recapitalizations, refinancing, growth initiatives and other corporate purposes.

The company is externally managed by Crescent Cap Advisors LLC, an affiliate of Crescent Capital Group LP, an investment firm specializing in credit and alternative investments.